By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Colony stimulating factors > Eflapegrastim
Colony stimulating factors

Eflapegrastim

https://themeditary.com/drug/eflapegrastim-6129.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 13, 2023  Additional Content by TheMediTary.Com

Generic name: eflapegrastim [ ef-la-peg-ra-stim ]

Drug class: Colony stimulating factors

Dosage form: subcutaneous solution (xnst 13.2 mg/0.6 ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Rolvedon

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Eflapegrastim?

Eflapegrastim is used in adults to treat neutropenia, a lack of certain white blood cells caused by cancer, chemotherapy, or by other conditions.

Eflapegrastim is used in adults to treat neutropenia, a lack of certain white blood cells caused by cancer, bone marrow transplant, receiving chemotherapy, or by other conditions.

Eflapegrastim may also be used for purposes not listed in this medication guide.

Warnings

Eflapegrastim can cause your spleen to become enlarged and it could rupture (tear). Call your doctor right away if you have sudden or severe pain in your left upper stomach spreading up to your shoulder.

How should I take Eflapegrastim

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Eflapegrastim is injected under the skin by a healthcare provider.

You will receive 1 injection of eflapegrastim for each cycle of chemotherapy. You should not receive this medicine for 14 days before or within 24 hours after your dose of chemotherapy.

You will need frequent medical tests.

Dosing information

Usual Adult Dose for Neutropenia Associated with Chemotherapy:

Usual dose: 13.2 mg subcutaneously once per chemotherapy cycle

Comments:
-Dose should be given at least 24 hours after cytotoxic chemotherapy.
-This drug should not be administered within the period from 14 days before to 24 hours after administration of cytotoxic chemotherapy.
-This drug is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.

Use: To decrease the incidence of infection, manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of neutropenia and fever.

Detailed Eflapegrastim dosage information
Eflapegrastim Dosage information (more detail)

Before Taking

You should not use eflapegrastim if you are allergic to eflapegrastim, filgrastim, or pegeflapegrastim.

Tell your doctor if you have ever had:

  • sickle cell disorder; or

  • kidney disease.

Tell your doctor if you are pregnant or breastfeeding.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your eflapegrastim injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Eflapegrastim?

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Eflapegrastim side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Eflapegrastim can cause your spleen to become enlarged and it could rupture (tear). Call your doctor right away if you have sudden or severe pain in your left upper stomach spreading up to your shoulder.

Capillary leak syndrome is a rare but serious side effect. Call your doctor right away if you have signs of this condition: stuffy or runny nose followed by tiredness, thirst, decreased urination, trouble breathing, and sudden swelling or weight gain.

Eflapegrastim may cause serious side effects. Call your doctor at once if you have:

  • shortness of breath or rapid breathing;

  • pain or trouble breathing;

  • easy bruising, unusual bleeding, purple or red spots under your skin;

  • abdominal pain, tiredness, back pain;

  • signs of infection-- fever, chills, sore throat, body aches, unusual tiredness, loss of appetite; or

  • kidney problems--little or no urinating, blood in your urine, swelling in your face or ankles.

Common side effects of eflapegrastim may include:

  • nausea, diarrhea;

  • bone, muscle, or joint pain;

  • back pain;

  • headache;

  • tiredness;

  • rash;

  • fever; or

  • pale skin, feeling light-headed or short of breath, cold hands and feet.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Eflapegrastim Side Effects

What other drugs will affect Eflapegrastim?

Other drugs may affect eflapegrastim, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

More about Eflapegrastim (Eflapegrastim [ ef-la-peg-ra-stim ])

Dosage information
Eflapegrastim Side Effects
During pregnancy
Drug images
Side effects
Drug class: Colony stimulating factors

Related treatment guides

Neutropenia Associated with Chemotherapy
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by